Axsome Therapeutics (AXSM) Shareholder's Equity (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.18% |
| Dec 31, 2025 | 19.76% |
| Sep 30, 2025 | 0.89% |
| Jun 30, 2025 | 37.35% |
| Mar 31, 2025 | -6.68% |
| Dec 31, 2024 | -38.63% |
| Sep 30, 2024 | -9.68% |
| Jun 30, 2024 | -28.59% |
| Mar 31, 2024 | -24.58% |
| Dec 31, 2023 | -29.14% |
| Sep 30, 2023 | -3.33% |
| Jun 30, 2023 | 149.35% |
| Mar 31, 2023 | 2.06% |
| Dec 31, 2022 | -30.38% |
| Sep 30, 2022 | 935.34% |
| Jun 30, 2022 | 3.41% |
| Mar 31, 2022 | -5.97% |
| Dec 31, 2021 | -63.41% |
| Sep 30, 2021 | -40.20% |
| Jun 30, 2021 | -25.81% |
| Mar 31, 2021 | -15.38% |
| Dec 31, 2020 | -15.87% |
| Sep 30, 2020 | -12.31% |
| Jun 30, 2020 | -1.23% |
| Mar 31, 2020 | -12.63% |
| Dec 31, 2019 | 2,519.57% |
| Sep 30, 2019 | -71.90% |
| Jun 30, 2019 | 39.77% |
| Mar 31, 2019 | 1,752.36% |
| Dec 31, 2018 | 26.28% |
| Sep 30, 2018 | -89.40% |
| Jun 30, 2018 | -44.31% |
| Mar 31, 2018 | -24.71% |
| Dec 31, 2017 | -0.72% |
| Sep 30, 2017 | -26.00% |
| Jun 30, 2017 | -22.29% |
| Mar 31, 2017 | 35.74% |
| Dec 31, 2016 | -23.46% |
| Sep 30, 2016 | -19.26% |
| Jun 30, 2016 | -15.35% |
| Mar 31, 2016 | -11.22% |